Maplight Therapeutics, Inc. · NASDAQ:MPLT

Catalyst4, Inc. reported a 45.10% stake in Maplight Therapeutics, Inc. (Schedule 13D)

Event Oct 28, 2025 · Filed Nov 20, 2025

Catalyst4, Inc. reported a 45.10% stake in Maplight Therapeutics, Inc., 19,697,464 shares, with active intent on Oct 28, 2025. Filed Nov 20, 2025 (Schedule 13D).

Stake
45.10%
Shares
19,697,464
Intent
Active
What changed
Crossed above 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Catalyst4, Inc.45.10%19,697,464
Robert Brown45.10%19,697,464
Ekemini Riley45.10%19,697,464
Mark Vorsatz45.10%19,697,464

Source

View original at SEC

Related